Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Barritt AS 4th"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-12 z 12
    Tytuł:
    Changing opportunities for liver transplant for patients with hepatocellular carcinoma.
    Autorzy:
    Zendel A; Division of Abdominal Transplant Surgery, Department of Surgery, University of North Carlina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA.
    Watkins R; Division of Abdominal Transplant Surgery, Department of Surgery, University of North Carlina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA.
    Moon AM; Division of GI Medicine, Department of Medicine, University of North Carlina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA.
    Gerber DA; Division of Abdominal Transplant Surgery, Department of Surgery, University of North Carlina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA.
    Barritt AS 4th; Division of GI Medicine, Department of Medicine, University of North Carlina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA.
    Desai CS; Division of Abdominal Transplant Surgery, Department of Surgery, University of North Carlina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA.
    Pokaż więcej
    Źródło:
    Clinical transplantation [Clin Transplant] 2022 May; Vol. 36 (5), pp. e14609. Date of Electronic Publication: 2022 Feb 20.
    Typ publikacji:
    Journal Article; Research Support, U.S. Gov't, P.H.S.
    MeSH Terms:
    Carcinoma, Hepatocellular*/pathology
    Carcinoma, Hepatocellular*/surgery
    End Stage Liver Disease*
    Liver Neoplasms*/pathology
    Liver Neoplasms*/surgery
    Liver Transplantation*
    Tissue and Organ Procurement*
    Humans ; Severity of Illness Index ; Waiting Lists
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Review article: role of glucagon-like peptide-1 receptor agonists in non-alcoholic steatohepatitis, obesity and diabetes-what hepatologists need to know.
    Autorzy:
    Barritt AS 4th; Division of Gastroenterology and Hepatology, UNC Liver Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
    Marshman E; Spirit Medical Communications, Manchester, UK.
    Noureddin M; Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
    Pokaż więcej
    Źródło:
    Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2022 Apr; Vol. 55 (8), pp. 944-959. Date of Electronic Publication: 2022 Mar 09.
    Typ publikacji:
    Journal Article; Review; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Diabetes Mellitus, Type 2*/complications
    Diabetes Mellitus, Type 2*/drug therapy
    Gastroenterologists*
    Non-alcoholic Fatty Liver Disease*/complications
    Non-alcoholic Fatty Liver Disease*/drug therapy
    Pancreatitis*/complications
    Acute Disease ; Glucagon-Like Peptide-1 Receptor/agonists ; Humans ; Hypoglycemic Agents/adverse effects ; Obesity/complications ; Obesity/drug therapy
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Editorial: targeting liver biopsy in NAFLD-the need to expand our non-invasive tools. Authors' reply.
    Autorzy:
    Kim HP; University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
    Mospan AR; Target RWE, Durham, North Carolina, USA.
    Fried MW; Target RWE, Durham, North Carolina, USA.
    Barritt AS 4th; University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
    Pokaż więcej
    Corporate Authors:
    TARGET-NASH Investigators
    Źródło:
    Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2022 Jan; Vol. 55 (1), pp. 128.
    Typ publikacji:
    Editorial; Comment
    MeSH Terms:
    Digestive System Surgical Procedures*
    Non-alcoholic Fatty Liver Disease*/diagnosis
    Biopsy ; Humans ; Liver
    Opinia redakcyjna
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Liver biopsy in the real world-reporting, expert concordance and correlation with a pragmatic clinical diagnosis.
    Autorzy:
    Kim HP; University of North Carolina, Chapel Hill, NC, USA.
    Idowu MO; Virginia Commonwealth University, Richmond, VA, USA.
    Mospan AR; Target RWE, Durham, NC, USA.
    Allmon AG; Target RWE, Durham, NC, USA.
    Roden M; Department of Endocrinology and Diabetology, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany.; Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University, Düsseldorf, Germany.; German Center for Diabetes Research (DZD), Partner Düsseldorf, Germany.
    Newsome P; University of Birmingham, Birmingham, UK.
    Lok AS; University of Michigan, Ann Arbor, MI, USA.
    Thuluvath PJ; Mercy Medical Center, Baltimore, MD, USA.; University of Maryland School of Medicine, Baltimore, MD, USA.
    Taunk J; Advanced Gastroenterology Associates, Palm Harbor, FL, USA.
    Fried MW; Target RWE, Durham, NC, USA.
    Sanyal AJ; Virginia Commonwealth University, Richmond, VA, USA.
    Barritt AS 4th; University of North Carolina, Chapel Hill, NC, USA.
    Pokaż więcej
    Corporate Authors:
    TARGET-NASH Investigators
    Źródło:
    Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Dec; Vol. 54 (11-12), pp. 1472-1480. Date of Electronic Publication: 2021 Oct 25.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural
    MeSH Terms:
    Diabetes Mellitus, Type 2*/pathology
    Non-alcoholic Fatty Liver Disease*/diagnosis
    Non-alcoholic Fatty Liver Disease*/pathology
    Biopsy ; Humans ; Liver/pathology ; Liver Cirrhosis/diagnosis ; Liver Cirrhosis/pathology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Letter: are opioid prescriptions associated with hepatic encephalopathy in patients with compensated cirrhosis? Authors' reply.
    Autorzy:
    Moon AM; Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
    Jiang Y; Department of Statistical Science, Duke University, Durham, NC, USA.
    Rogal SS; Division of Gastroenterology, Hepatology, and Nutrition, University of Pittsburgh, Pittsburgh, PA, USA.
    Tapper EB; Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, MI, USA.; Gastroenterology Section, VA Ann Arbor Healthcare System, Ann Arbor, MI, USA.
    Lieber SR; Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
    Barritt AS 4th; Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
    Pokaż więcej
    Źródło:
    Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2020 Apr; Vol. 51 (7), pp. 743-744.
    Typ publikacji:
    Letter; Research Support, N.I.H., Extramural; Comment
    MeSH Terms:
    Hepatic Encephalopathy*
    Analgesics, Opioid ; Cohort Studies ; Humans ; Liver Cirrhosis ; Prescriptions
    Raport
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Opioid prescriptions are associated with hepatic encephalopathy in a national cohort of patients with compensated cirrhosis.
    Autorzy:
    Moon AM; Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
    Jiang Y; Department of Biostatistics, University of North Carolina Gillings School of Global Public Health, Chapel Hill, NC, USA.
    Rogal SS; Division of Gastroenterology, Hepatology, and Nutrition, University of Pittsburgh, Pittsburgh, PA, USA.
    Tapper EB; Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, MI, USA.; Gastroenterology Section, VA Ann Arbor Healthcare System, Ann Arbor, MI, USA.
    Lieber SR; Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
    Barritt AS 4th; Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
    Pokaż więcej
    Źródło:
    Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2020 Mar; Vol. 51 (6), pp. 652-660. Date of Electronic Publication: 2020 Jan 21.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural
    MeSH Terms:
    Analgesics, Opioid/*therapeutic use
    Drug Prescriptions/*statistics & numerical data
    Hepatic Encephalopathy/*epidemiology
    Liver Cirrhosis/*drug therapy
    Liver Cirrhosis/*epidemiology
    Adolescent ; Adult ; Cohort Studies ; Databases, Factual ; Female ; Hepatic Encephalopathy/etiology ; Humans ; Incidence ; Male ; Middle Aged ; Practice Patterns, Physicians'/statistics & numerical data ; Risk Factors ; United States/epidemiology ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    In inpatients with cirrhosis opioid use is common and associated with length of stay and persistent use post-discharge.
    Autorzy:
    Moon AM; Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States of America.
    Jiang Y; Department of Statistical Science, Duke University, Durham, NC, United States of America.
    Rogal SS; Division of Gastroenterology, Hepatology, and Nutrition, University of Pittsburgh, Pittsburgh, PA, United States of America.
    Becker J; North Carolina Translational and Clinical Sciences Institute (NC TraCS), University of North Carolina School of Medicine, Chapel Hill, NC, United States of America.
    Barritt AS 4th; Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States of America.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2020 Feb 26; Vol. 15 (2), pp. e0229497. Date of Electronic Publication: 2020 Feb 26 (Print Publication: 2020).
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural
    MeSH Terms:
    Analgesics, Opioid/*therapeutic use
    Fibrosis/*complications
    Fibrosis/*drug therapy
    Adult ; Female ; Hospitalization ; Humans ; Inpatients ; Length of Stay ; Liver Cirrhosis/complications ; Male ; Middle Aged ; Opioid-Related Disorders/drug therapy ; Pain, Postoperative/drug therapy ; Patient Discharge ; Practice Patterns, Physicians'/trends ; Prescriptions ; Retrospective Studies ; United States
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    The impact of post-transplant diabetes mellitus on liver transplant outcomes.
    Autorzy:
    Lieber SR; Division of Gastroenterology and Hepatology, Department of Medicine, UNC School of Medicine, Chapel Hill, North Carolina.
    Lee RA; Department of Pharmacy, UNC Health Care, Chapel Hill, North Carolina.
    Jiang Y; Department of Biostatistics, UNC Gillings School of Public Health, Chapel Hill, North Carolina.
    Reuter C; Department of Specialty Pharmacy, Ochsner Medical Center, New Orleans, Louisiana.
    Watkins R; Department of Biostatistics, UNC Gillings School of Public Health, Chapel Hill, North Carolina.
    Szempruch K; Department of Pharmacy, UNC Health Care, Chapel Hill, North Carolina.
    Gerber DA; Department of Surgery, UNC School of Medicine, Chapel Hill, North Carolina.
    Desai CS; Department of Surgery, UNC School of Medicine, Chapel Hill, North Carolina.
    DeCherney GS; Division of Endocrinology, Department of Medicine, UNC School of Medicine, Chapel Hill, North Carolina.
    Barritt AS 4th; Division of Gastroenterology and Hepatology, Department of Medicine, UNC School of Medicine, Chapel Hill, North Carolina.
    Pokaż więcej
    Źródło:
    Clinical transplantation [Clin Transplant] 2019 Jun; Vol. 33 (6), pp. e13554. Date of Electronic Publication: 2019 Apr 23.
    Typ publikacji:
    Clinical Trial; Journal Article; Research Support, N.I.H., Extramural
    MeSH Terms:
    Diabetes Mellitus/*mortality
    Graft Rejection/*mortality
    Liver Diseases/*mortality
    Liver Transplantation/*mortality
    Postoperative Complications/*mortality
    Adult ; Diabetes Mellitus/epidemiology ; Diabetes Mellitus/physiopathology ; Female ; Follow-Up Studies ; Graft Rejection/etiology ; Graft Rejection/pathology ; Graft Survival ; Humans ; Incidence ; Liver Diseases/surgery ; Liver Transplantation/adverse effects ; Male ; Middle Aged ; North Carolina/epidemiology ; Postoperative Complications/etiology ; Postoperative Complications/pathology ; Prognosis ; Retrospective Studies ; Risk Factors ; Survival Rate
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Randomised clinical trial: a leucine-metformin-sildenafil combination (NS-0200) vs placebo in patients with non-alcoholic fatty liver disease.
    Autorzy:
    Chalasani N; Indiana University School of Medicine, Indianapolis, IN, USA.
    Vuppalanchi R; Indiana University School of Medicine, Indianapolis, IN, USA.
    Rinella M; Northwestern University, Chicago, IL, USA.
    Middleton MS; University of California at San Diego, San Diego, CA, USA.
    Siddiqui MS; Virginia Commonwealth University, Richmond, VA, USA.
    Barritt AS 4th; University of North Carolina, Chapel Hill, NC, USA.
    Kolterman O; NuSirt Biopharma, Nashville, TN, USA.
    Flores O; NuSirt Biopharma, Nashville, TN, USA.
    Alonso C; OWL Metabolomics, Derio, Spain.
    Iruarrizaga-Lejarreta M; OWL Metabolomics, Derio, Spain.
    Gil-Redondo R; OWL Metabolomics, Derio, Spain.
    Sirlin CB; University of California at San Diego, San Diego, CA, USA.
    Zemel MB; NuSirt Biopharma, Nashville, TN, USA.
    Pokaż więcej
    Źródło:
    Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2018 Jun; Vol. 47 (12), pp. 1639-1651. Date of Electronic Publication: 2018 Apr 25.
    Typ publikacji:
    Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Leucine/*administration & dosage
    Metformin/*administration & dosage
    Non-alcoholic Fatty Liver Disease/*drug therapy
    Sildenafil Citrate/*administration & dosage
    Adult ; Alanine Transaminase/metabolism ; Cohort Studies ; Double-Blind Method ; Drug Combinations ; Female ; Humans ; Lipids/chemistry ; Magnetic Resonance Imaging/methods ; Male ; Metformin/therapeutic use ; Non-alcoholic Fatty Liver Disease/pathology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
      Wyświetlanie 1-12 z 12

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies